NewType is a public benefit company developing Bacteria-as-a-Service (BaaS) technology to engineer organisms for the elimination of nano and microplastic pollution in wastewater, industrial composters, and soil.
NewType is a public benefit corporation focused on engineering organisms to address nano and microplastic pollution. The company leverages expertise in enzymatic plastic recycling to develop Bacteria-as-a-Service (BaaS) solutions designed for wastewater treatment, industrial composting, and soil remediation. Additionally, the company provides commercial testing services for small plastic particles and PFAS contamination. Their approach combines biotechnology and cleantech to create scalable, low-cost technologies that aim to remove plastic waste from natural and industrial environments, supporting a more sustainable and circular economy. By empowering bacteria to consume plastic, NewType offers specialized biological tools to restore environments and mitigate the long-term health and ecological risks posed by plastic particle accumulation. The company works with partners in wastewater management, waste processing, and environmental remediation to deploy these solutions and ensure broader access to sustainable environmental practices.